Advanced glycation end products: Key players in skin aging? - Wikidata - awgldk - TriplyDB

Advanced glycation end products: Key players in skin aging?

Advanced glycation end products: Key players in skin aging?

http://www.wikidata.org/entity/Q36643573

about

Role of advanced glycation end products in cellular signaling Skin disorders in diabetes mellitus: an epidemiology and physiopathology review Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature [Epidermal aging and anti-aging strategies].An immunohistochemical panel to assess ultraviolet radiation-associated oxidative skin injury.FOXO1 differentially regulates both normal and diabetic wound healing.Relationship of advanced glycation end products and their receptor to pelvic organ prolapse.Oxidative stress in aging human skin.α-glucosidase and glycation inhibitory effects of costus speciosus leaves RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast Cells Inhibitory action on the production of advanced glycation end products (AGEs) and suppression of free radicals in vitro by a Sri Lankan polyherbal formulation Nawarathne Kalka.Voluntary exercise improves murine dermal connective tissue status in high-fat diet-induced obesity.Protein carbamylation is a hallmark of aging Effect of Aging on Periodontal Inflammation, Microbial Colonization, and Disease Susceptibility.Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs.In-vivo, non-invasive detection of hyperglycemic states in animal models using mm-wave spectroscopy A new dermocosmetic containing retinaldehyde, delta-tocopherol glucoside and glycylglycine oleamide for managing naturally aged skin: results from in vitro to clinical studies.Prevention of dicarbonyl-mediated advanced glycation by glyoxalases: implication in skin aging.Oxidative stress, protein glycation and nutrition--interactions relevant to health and disease throughout the lifecycle.Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition.A longitudinal study of the diabetic skin and wound microbiome.Increased expression of damage-associated molecular patterns (DAMPs) in osteoarthritis of human knee joint compared to hip joint.Molecular characterization of glycation-associated skin ageing: an alternative skin model to study in vitro antiglycation activity of topical cosmeceutical and pharmaceutical formulations.Cutaneous Manifestations of Diabetes Mellitus: A Review.Hypoxia driven glycation: Mechanisms and therapeutic opportunities.Phytochemistry and pharmacological potential of Cassia absus - a review.Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than Nε-(Carboxymethyl) Lysine.Classification of skin phenotypes caused by diabetes mellitus using complex scattering parameters in the millimeter-wave frequency range.Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.Anti-glycative effects of asiatic acid in human keratinocyte cells.Breathing to younger skin: 'reversing the molecular mechanism of skin aging with yoga'Comparative Analysis of AGE and RAGE Levels in Human Somatic and Embryonic Stem Cells under H2O2-Induced Noncytotoxic Oxidative Stress Conditions.Advanced glycation end products affect cholesterol homeostasis by impairing ABCA1 expression on macrophages.Skin aging parameters: A window to heart block.Maillard Proteomics: Opening New Pages.Probing Protein Glycation by Chromatography and Mass Spectrometry: Analysis of Glycation Adducts.Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study.Oxidative stress induces renal failure: A review of possible molecular pathways.

P2860

Q27003423-C563C498-50A9-482A-9B20-A3775EA841BB Q28072255-C1AA55AC-A642-4AD9-9E34-F76DDB439918 Q28074693-7E10D245-A97F-4CFC-A0E2-911B65825440 Q30315912-91F9F277-FEEB-4CB4-9476-D5030F2BFCDA Q35359199-DEE6F301-3B8D-4B38-BD03-4A767A2A8B03 Q35543164-10324B21-D6BD-4703-B0BB-353D006F026F Q35631976-76A561AD-71B0-4FAF-8695-741B1840C50C Q35833994-9C4BB60C-002F-4641-B094-9A9E225DCABD Q35884279-60D2376C-F9A4-49E6-BDDB-CE8EBA553365 Q35970395-28B97EC2-71F8-4DA6-95FB-BBF740F46856 Q36071466-D667E829-CFF2-4782-BD28-04509C13627A Q36274866-041C90A3-33F1-4F80-A204-6F71C848BAB9 Q36563327-54E073A6-2C30-4E15-BEC0-9AE4D30902E3 Q36714894-041D3E88-D62D-4CFF-8CE4-0899F5FFEF26 Q36996149-BAA6C3A7-B55C-4EB1-81A2-FD45EC1F6565 Q37285455-E6587084-8687-41F8-9269-47C32A2283F6 Q37629561-B46F412B-53AA-4347-BA5E-2C81FB158656 Q38197357-263A7AFA-2D72-462F-BC7B-DCA1929E36FC Q38216061-FA5BB1EB-8E43-490F-8860-2A4EC8DD97DE Q38658807-108A494F-B99E-4344-A7B5-79C180195A47 Q38663267-D989107B-D683-4834-B7D9-9F85EED7BFEF Q38675866-455679B4-B70B-4151-A6BC-28FDB5B0E28A Q38846666-742D1D32-E41A-480E-85EB-845FCD86FD42 Q39218289-C869702D-1248-4C9F-A6C6-85657A9B0178 Q39331191-D0BA8328-55F8-4BC8-9898-446DB5AB12BF Q40066642-7719ABB5-0695-48E2-BE96-95A44628D745 Q40295046-687041EF-B07F-47E1-A005-710307F3184F Q40955558-941E96DC-3A65-4B56-9389-444D1682F2AA Q41062586-6502044E-BA99-454E-909D-57982C99CFF0 Q41350279-E34F31D7-12D6-4B89-AA56-4065AEDF4950 Q41836455-816C431A-260F-46AB-9C62-956A0B588B17 Q42182187-04ABE638-6DE3-44C2-82DC-6953EC6366A6 Q42358613-D6649EC4-AEF5-44CA-ABFF-D93EE81DBB40 Q46268472-3394809B-9072-4487-BDDE-2841D5DB185F Q46537743-3AE53A9C-3A91-42C5-A69E-C9DA1294B783 Q46786724-113A9CFE-740F-4675-BA65-86DDEB6A54F5 Q47303198-031269D6-5A3F-41F1-B016-ED6768D6307A Q47340371-3E2CBD1F-30BD-4450-A5CD-4FC0CD6B8916 Q47358302-0346507C-FB98-4533-B96D-93F56F054A70 Q47642456-B2F03FFA-A9E0-4328-AEF8-6EA39EFB9EB6

P2860

Advanced glycation end products: Key players in skin aging?

http://www.wikidata.org/entity/Q36643573

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Advanced glycation end products: Key players in skin aging?

@ast

Advanced glycation end products: Key players in skin aging?

@en

type

label

Advanced glycation end products: Key players in skin aging?

@ast

Advanced glycation end products: Key players in skin aging?

@en

prefLabel

Advanced glycation end products: Key players in skin aging?

@ast

Advanced glycation end products: Key players in skin aging?

@en

P1433

Q36643573-23AA4DE0-DB6A-46D6-BBCD-692FBDC94D67

P1476

Q36643573-48E2F022-27F8-433A-8BF3-721E4B8A6850

P2093

Q36643573-296A59CF-E753-4846-96EA-5514B8739C25

Q36643573-B8B309D1-6C0A-403F-9A1F-6448971867AA

P2860

Q36643573-05328405-456B-4C2E-882E-3A89B6DF122C

Q36643573-0BA4681E-F196-431A-A1D4-4E342F394E01

Q36643573-0C8671A9-C98A-4399-A2B2-E440B078DFB8

Q36643573-10FF2014-306D-49F8-BDF6-3C4460D174D9

Q36643573-124CA281-BF20-4478-A3C0-77546F7F7FA9

Q36643573-147A0BD2-1E25-4684-B509-6FEF82E17EE1

Q36643573-17AAE78C-E724-4D5F-A35F-7A47C5F3AE54

Q36643573-18596C5C-564B-405E-80F4-E66176543B21

Q36643573-1AD0C95D-2068-4030-9161-77E4FD286279

Q36643573-1C125A90-F490-49DF-B1C5-D17FB4447C70

P304

Q36643573-4D8A443C-5B37-4938-B35F-6E456746F6A1

P31

Q36643573-EE87A1DE-D834-414A-A952-E8E4C0103774

P356

Q36643573-26226DE2-2E2E-4269-A885-547E82D05E75

P433

Q36643573-E9B4EF7B-538B-41B5-84BB-B4DE986E2861

P478

Q36643573-726FB9FD-E055-4B10-8571-44A107812C36

P577

Q36643573-B2A4D115-8DDF-4362-BA2E-550E7403B8B9

P5875

Q36643573-12D85C42-C1F9-4A91-880B-B8EAA0CFB8F1

P698

Q36643573-DDA95B5F-F6A7-43C2-9C8C-A8E415A543A0

P932

Q36643573-01D94C42-B27C-456F-8C83-53EE2045BB42

P356

P1433

Dermato-endocrinology

P1476

Advanced glycation end products: Key players in skin aging?

@en

P2093

Markus Böhm

http://www.w3.org/2001/XMLSchema#string

Paraskevi Gkogkolou

http://www.w3.org/2001/XMLSchema#string

P2860

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)

Tobacco smoke is a source of toxic reactive glycation products

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

Therapeutic potential of breakers of advanced glycation end product-protein crosslinks

Prevention and repair of protein damage by the Maillard reaction in vivo

Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process

P304

259-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/DERM.22028

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235881432

http://www.w3.org/2001/XMLSchema#string

P698

23467327

http://www.w3.org/2001/XMLSchema#string

P932

3583887

http://www.w3.org/2001/XMLSchema#string